My Cart

Cadherin-3

Cadherin-3 Overview

English NameCadherin 3Approved Drugs0
Drugs in Clinical Trials7Target SynonymCadherin 3, Type 1, P-Cadherin (Placental),Placental Cadherin,CDHP,P-cadherin,CDH3,Cadherin 3,Calcium-Dependent Adhesion Protein, Placental,Cadherin 3, P-Cadherin (Placental),Cadherin-3,HJMD,PCAD
Highest Development StagePhase 2 Clinical
English NameCadherin 3
Target SynonymCadherin 3, Type 1, P-Cadherin (Placental),Placental Cadherin,CDHP,P-cadherin,CDH3,Cadherin 3,Calcium-Dependent Adhesion Protein, Placental,Cadherin 3, P-Cadherin (Placental),Cadherin-3,HJMD,PCAD
Approved Drugs0
Drugs in Clinical Trials7
Highest Development StagePhase 2 Clinical

Cadherin-3 Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (1)Mouse (1)Cynomolgus (1)

  • Tag

    His Tag (3)

  • Conjugate

    Unconjugated (3)

Cadherin-3 Background

Cadherin-3 (CDH3), also known as P-Cadherin, is a classical cadherin that functions as a calcium-dependent glycoprotein mediating cell-cell adhesion. Structurally, it is characterized by five extracellular cadherin repeats, a single transmembrane domain, and a highly conserved cytoplasmic tail. The CDH3 gene resides within a cadherin cluster on chromosome 16q, a genomic region linked to loss of heterozygosity in breast and prostate cancer. Furthermore, aberrant expression of the protein is implicated in the pathology of cervical adenocarcinoma.

Cadherin-3 Synonyms

CDH3,CDHP,Cadherin-3,P-cadherin

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
STEMVACEP-101Phase 2 ClinicalEpithanyBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; HR-positive breast cancer; Lung Neoplasms; Triple Negative Breast Neoplasms
Details
BC-3195BC3195; BC-3195Phase 2 ClinicalWuxi BioCityNeoplasm Metastasis; Neoplasms; Solid tumours
Details
FF-21101-Y-90FF-21101-Y-90; PPMX-T002Phase 1 ClinicalFujifilm Holdings CorpSolid tumours
Details
FF-21101FF-21101Phase 1 ClinicalPerseus Proteomics IncBile Duct Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
TRAILR2/CDH3 bispecific antibody (Boehringer Ingelheim)Phase 1 ClinicalBoehringer Ingelheim International GmbhNeoplasms
Details
AMG 305AMG 305; AMG-305Phase 1 ClinicalAmgen IncSolid tumours
Details
FF-21101InFF-21101InPhase 1 ClinicalPeptiDream IncSolid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland